PA

Peter Andersen

Senior Vice President of Global Research and Drug Discovery at Alk-Abello

Copenhagen, Denmark

About

Peter Sejer Andersen is based out of Copenhagen, Hovedstaden, and is the Non-Executive Director of Allegria Therapeutics and Senior Vice President of Global Research and Drug Discovery of Alk-Abello. Peter previously worked at Symphogen as a Director of Antibody Discovery. Peter Sejer Andersen attended the University of Copenhagen.

Position in the VCSift Database

  • 1 investors hold the Senior Vice President of Global Research and Drug Discovery role in VCSift. Peter Andersen is one of them.
  • 666 investors are based in Copenhagen, Hovedstaden, Denmark.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Contact Information

em••••@example.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Peter

Search Investors